Recently, Lancet Neurology published an article on the long-term follow up for a stem cell treatment on MS patients. This treatment involves high-dose chemotherapy to wipe out the immune system followed by stem cells to ‘reboot’ the immune system. The therapy has been studied for many years and is a very effective treatment for early, highly-aggressive, relapsing-remitting MS patients. However, safety issues persist and there are often other medications which can be used effectively in this... more


Dr. Saud A. Sadiq and researchers from the Tisch MS laboratory will present their work this week in San Francisco, CA at the ISSCR 2016 Annual Meeting. For a look at this year's event visit: We will have full updates of the research presented next week!


The FDA recently approved Zinbryta (daclizumab) for the treatment of adults with relapsing forms of multiple sclerosis. Zinbryta is a long-acting subcutaneous injection that is administered once a month. Zinbryta has shown efficacy in two large clinical trials, one of which compared this drug to Avonex. There are additional safety concerns with this medication, however, including possible damage to the liver. Patients on Zinbryta will have to perform blood tests to monitor liver function... more


The IMSMP is starting a new group for patients of the Center, who want to socialize and support one another yet may have difficulty traveling to the city. The group meets over the phone, once a month on Wednesdays. There are also openings to join the support group for newly diagnosed patients. For more information on either of these groups, please contact the Social Work Department at (212) 265-8070.


In observance of Memorial Day, the IMSMP will close today at 2:30pm and re-open on Tuesday, May 31st. For any emergency, a neurologist will be on-call and may be reached at (212) 265-8070. We thank women and men everywhere for their service to our country and we wish you a safe & healthy holiday weekend.


The spring issue of the IMSMP newsletter, Healing MS is here!


Do you suffer from seasonal allergies? If so, contact the nurse's phone line at the IMSMP to discuss which allergy medication is right for you. Call (212) 265-8070.



Because you deserve only the best in MS healthcare. Experience the difference.

Newsletter Sign Up

Join our mailing list today!  Receive the latest information and updates happening in MS research, treatment and care including, Healing MS, the IMSMP newsletter.

* We don’t share your information with anyone.